Select a CME program

The following interactive multimedia activities are available for this therapeutic area:

Gout

  • CaseBook Challenges: Managing Gout, Hyperuricemia and
    Comorbidities—Dialogue with the Experts


    An Interactive CME/CE Program with Patient Case Videos


    Presenters: George L. Bakris, MD, FASH, FASN, Paul P. Doghramji, MD, FAAFP, Robert T. Keenan, MD, MPH, Steven H. Silber, DO, FACEP

    As the prevalence of gout continues to increase in the United States, primary care and emergency department clinicians can expect to see more patients who present with the symptoms and complications of this disease. In addition to treating and preventing acute flares and halting disease progression, clinical strategies for the management of gout and hyperuricemia must include considerations for common renal and cardiometabolic conditions, including hypertension and diabetes, which are associated with elevated serum urate levels.

    Utilizing patient video cases, this CME/CE program provides expert discussion of the everyday challenges clinicians face in diagnosing and treating gout, including key steps in making a presumptive diagnosis, the rationale and sequencing of pharmacotherapy for acute and chronic gout, the importance of reaching target serum urate level, and communicating with patients to improve both their understanding of the disease process and their adherence to long-term treatment.

  • CaseBook Consults: Improving Outcomes in Gout

    Presenters: Paul Doghramji, MD, FAAFP, Brian F. Mandell, MD, PhD, FACR, MACP, and Richard S. Pope, MPAS, PA-C, DFAAPA

    Despite the fact that gout can be diagnosed with relative certainty and that effective therapies have been available for a long time, it is underdiagnosed and undertreated, management is less than optimal, and poor clinical outcomes are not uncommon. Through consultative discussion and patient case video illustrations, it is the aim of this CE activity to provide clinical information that will assist primary care providers to confidently make a presumptive diagnosis and to improve overall management and patient outcomes. The rationale, timing and duration of pharmacologic treatment will be discussed as well as the importance of adherence to therapy and achieving a target SUA level.